Bausch Health Companies Inc. (BHC) Comparison with companies in other sectors?

Bausch Health Companies Inc. has a share price of 369.55M. You can analyze Bausch Health Companies Inc. (BHC) competitors across different market sectors through stock heatmaps.

What are BHC's NET and operating margins?

Bausch Health Companies Inc. (BHC) operating margin is around 0.16, and net profit margin is approximately -0.00 as of the latest reports.

In what way does BHC's earnings per share (EPS) trend reflect its financial momentum?

Bausch Health Companies Inc. (BHC) EPS is -0.12 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Bausch Health Companies Inc. is -57.42, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Bausch Health Companies Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Bausch Health Companies Inc. like P/E which is -58.72, P/B which is 0.00, and PEG which is -7.05. Compare them with sector averages to evaluate if the stock is priced fairly.

Bausch Health Companies Inc.

BHC•NYSE

Healthcare

Drug Manufacturers - Specialty & Generic

$6.89

$0.13(1.85%)

Bausch Health Companies Inc. (BHC) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.12

P/E Ratio

-57.42

ROE

0.05%

Net Margin

-0.00%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.55B

Shares OutstandingTotal number of shares issued

$369.55M

Book Value/ShareNet worth per share

$72.89

Revenue/ShareAnnual revenue per share

$26.49

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.12

Net MarginNet income as percentage of revenue

-0.44%

Operating MarginOperating income as percentage of revenue

16.43%

ROEReturn on shareholders' equity

4.70%

ROAReturn on total assets

-0.16%

ROCEReturn on capital employed

5.97%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$3.40

Cash/ShareCash and equivalents per share

$3.13

FCF YieldFree cash flow as percentage of market cap

48.40%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BHCFinancial Ratios Analysis details for BHC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BHCSector Benchmarking details for BHC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Bausch Health Companies Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Bausch Health Companies Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Bausch Health Companies Inc.'s unique business strengths and challenges.

Key Financial Metrics for Bausch Health Companies Inc.

For Bausch Health Companies Inc., essential financial indicators include EPS -0.12, PE -57.42, and ROE 0.05. These key ratios reveal insights into Bausch Health Companies Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Bausch Health Companies Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Bausch Health Companies Inc.

Metrics like Net Margin -0.44% and ROA -0.16% shed light on how well Bausch Health Companies Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Bausch Health Companies Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Bausch Health Companies Inc.

Using ratios such as P/B Ratio - and PEG Ratio -7.05, investors can assess whether Bausch Health Companies Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Bausch Health Companies Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Bausch Health Companies Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $3.40, provide a snapshot of Bausch Health Companies Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Bausch Health Companies Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Bausch Health Companies Inc.

Investing in Bausch Health Companies Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Bausch Health Companies Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;